JUNIUS DANIEL M

Average Profitability
10.22%
Insider Buys Quantity
6
Insider Buys Sum
$490,200.00
Insider Sells Quantity
9
Insider Sells Sum
$10.4M

Insider Activity of JUNIUS DANIEL M

The largest purchase of all time was on 2015-08-03 and amounted to 2000 shares of IDEXX Laboratories, Inc. for $146,300.

The largest sale of all time was on 2021-08-10 and amounted to 2402 shares of IDEXX Laboratories, Inc. for $1.63M.

Biography of JUNIUS DANIEL M

No biography is available at this moment.

2023-05-10PurchaseGlycoMimetics, Inc.
GLYC
director
30,000
0.0441%
$1.56$46,800-1.14%
2023-02-16SaleIDEXX Laboratories, Inc.
IDXX
director
2,187
0.0027%
$511.68$1.12M-4.04%
2022-12-05SaleIDEXX Laboratories, Inc.
IDXX
director
3,046
0.0037%
$424.91$1.29M+13.25%
2022-11-17PurchaseGlycoMimetics, Inc.
GLYC
director
20,000
0.034%
$1.87$37,400-21.88%
2021-08-10SaleIDEXX Laboratories, Inc.
IDXX
director
2,402
0.0029%
$679.58$1.63M-20.2%
2021-05-21SaleIDEXX Laboratories, Inc.
IDXX
director
2,500
0.0029%
$539.57$1.35M+12.68%
2021-02-22SaleIDEXX Laboratories, Inc.
IDXX
director
1,898
0.0022%
$538.57$1.02M+13.16%
2020-08-20SaleIDEXX Laboratories, Inc.
IDXX
director
3,722
0.0044%
$382.61$1.42M+29.67%
2020-05-19SaleIDEXX Laboratories, Inc.
IDXX
director
4,000
0.0047%
$295.61$1.18M+54.07%
2020-03-09PurchaseGlycoMimetics, Inc.
GLYC
director
40,000
0.0969%
$3.40$136,000+8.7%
2019-08-13PurchaseGlycoMimetics, Inc.
GLYC
director
20,000
0.0462%
$3.18$63,600+26.42%
2018-02-28SaleIDEXX Laboratories, Inc.
IDXX
director
5,948
0.0046%
$127.37$757,620+11.08%
2017-02-08SaleIDEXX Laboratories, Inc.
IDXX
director
6,000
0.005%
$103.22$619,334+12.49%
2016-12-20PurchaseGlycoMimetics, Inc.
GLYC
director
10,000
0.0427%
$6.01$60,100+81.12%
2015-08-03PurchaseIDEXX Laboratories, Inc.
IDXX
director
2,000
0.0021%
$73.15$146,300+1.79%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.